Insmed Inc (INSM)
24.88
-0.04
(-0.14%)
USD |
NASDAQ |
Apr 26, 10:07
Insmed Shareholders Equity (Quarterly): -331.92M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -331.92M |
September 30, 2023 | -289.36M |
June 30, 2023 | -155.74M |
March 31, 2023 | -44.65M |
December 31, 2022 | 87.95M |
September 30, 2022 | -29.96M |
June 30, 2022 | 44.24M |
March 31, 2022 | 119.88M |
December 31, 2021 | 410.47M |
September 30, 2021 | 504.84M |
June 30, 2021 | 531.05M |
March 31, 2021 | 201.64M |
December 31, 2020 | 275.88M |
September 30, 2020 | 357.06M |
June 30, 2020 | 405.32M |
March 31, 2020 | 206.70M |
December 31, 2019 | 261.67M |
September 30, 2019 | 304.04M |
June 30, 2019 | 356.57M |
March 31, 2019 | 144.14M |
December 31, 2018 | 208.27M |
September 30, 2018 | 291.41M |
June 30, 2018 | 370.64M |
March 31, 2018 | 434.86M |
December 31, 2017 | 361.06M |
Date | Value |
---|---|
September 30, 2017 | 421.30M |
June 30, 2017 | 83.44M |
March 31, 2017 | 121.68M |
December 31, 2016 | 154.48M |
September 30, 2016 | 217.83M |
June 30, 2016 | 250.56M |
March 31, 2016 | 282.46M |
December 31, 2015 | 311.70M |
September 30, 2015 | 339.00M |
June 30, 2015 | 365.34M |
March 31, 2015 | 164.86M |
December 31, 2014 | 186.24M |
September 30, 2014 | 199.27M |
June 30, 2014 | 111.55M |
March 31, 2014 | 131.74M |
December 31, 2013 | 143.32M |
September 30, 2013 | 157.12M |
June 30, 2013 | 105.18M |
March 31, 2013 | 107.60M |
December 31, 2012 | 120.88M |
September 30, 2012 | 136.61M |
June 30, 2012 | 119.72M |
March 31, 2012 | 128.13M |
December 31, 2011 | 134.27M |
September 30, 2011 | 142.34M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-331.92M
Minimum
Dec 2023
531.05M
Maximum
Jun 2021
169.25M
Average
206.70M
Median
Mar 2020
Shareholders Equity (Quarterly) Benchmarks
NeuroMetrix Inc | 20.09M |
Intra-Cellular Therapies Inc | 591.42M |
Rhythm Pharmaceuticals Inc | 169.76M |
Amylyx Pharmaceuticals Inc | 433.43M |
AN2 Therapeutics Inc | 124.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.330B |
Total Liabilities (Quarterly) | 1.662B |
Debt to Equity Ratio | -3.481 |
Current Ratio | 4.118 |
Net Debt Paydown Yield | -1.62% |